Recurrent Nonsense Mutations at Arginine Residues Cause Severe Hemophilia B in Unrelated Hemophiliacs

Overview

Journal Hum Genet

Specialty Genetics

Date 1990 Apr 1

PMID 1969838

Citations 21

Authors

D D Koeberl

C D Bottema

G Sarkar

R P Ketterling

S H Chen

S S Sommer

Affiliations

Soon will be listed here.

Abstract

Direct sequencing of the regions of the factor IX gene of likely functional significance was performed in four patients with severe hemophilia B. In two of the individuals, a transition at the dinucleotide CpG caused a nonsense mutation at arginine 333. In the other two individuals, a transition at CpG caused a nonsense mutation at arginine 29. Since these patients are all unrelated, as shown by differing alleles of the TaqI polymorphism in intron four or extensive nonoverlapping pedigrees, the mutations arose independently. In addition, the origin of one arginine 333 mutation in one family has been traced to the germline of the maternal grandfather. The frequent occurrence of mutations at arginine codons that contain the sequence CGN can be explained by the dramatic elevation of transitions at CpG. As a result, approximately one in four individuals with hemophilia B is expected to have a mutation at arginine and nonsense mutations at one of six arginine residues should be common causes of severe hemophilia.

Citing Articles

Mutation analysis and characterisation of gene in haemophilia- B population of India.

Kulkarni S, Hegde R, Hegde S, Kulkarni S, Hanagvadi S, Das K Blood Res. 2021; 56(4):252-258.

PMID: 34880139 PMC: 8721457. DOI: 10.5045/br.2021.2021016.

Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations.

Branchini A, Ferrarese M, Campioni M, Castaman G, Mari R, Bernardi F Blood. 2017; 129(16):2303-2307.

PMID: 28196793 PMC: 5408560. DOI: 10.1182/blood-2016-09-738641.

G418-mediated ribosomal read-through of a nonsense mutation causing autosomal recessive proximal renal tubular acidosis.

Azimov R, Abuladze N, Sassani P, Newman D, Kao L, Liu W Am J Physiol Renal Physiol. 2008; 295(3):F633-41.

PMID: 18614622 PMC: 2653109. DOI: 10.1152/ajprenal.00015.2008.

Haemophilia A and haemophilia B: molecular insights.

Bowen D Mol Pathol. 2002; 55(2):127-44.

PMID: 11950963 PMC: 1187163. DOI: 10.1136/mp.55.2.127.

Haemophilia A and haemophilia B: molecular insights.

Bowen D Mol Pathol. 2002; 55(1):1-18.

PMID: 11836440 PMC: 1187139. DOI: 10.1136/mp.55.1.1.

References

Green P, Bentley D, MIBASHAN R, Nilsson I, Giannelli F . Molecular pathology of haemophilia B. EMBO J. 1989; 8(4):1067-72. PMC: 400915. DOI: 10.1002/j.1460-2075.1989.tb03474.x. View

Attree O, Vidaud D, Vidaud M, Amselem S, Lavergne J, Goossens M . Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior. Genomics. 1989; 4(3):266-72. DOI: 10.1016/0888-7543(89)90330-3. View

Tsang T, Bentley D, MIBASHAN R, Giannelli F . A factor IX mutation, verified by direct genomic sequencing, causes haemophilia B by a novel mechanism. EMBO J. 1988; 7(10):3009-15. PMC: 454685. DOI: 10.1002/j.1460-2075.1988.tb03164.x. View

Gyllensten U, Erlich H . Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci U S A. 1988; 85(20):7652-6. PMC: 282250. DOI: 10.1073/pnas.85.20.7652. View

Youssoufian H, Kazazian Jr H, Phillips D, Aronis S, Tsiftis G, Brown V . Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots. Nature. 1986; 324(6095):380-2. DOI: 10.1038/324380a0. View

Camerino G, Grzeschik K, Jaye M, de la Salle H, Tolstoshev P, Lecocq J . Regional localization on the human X chromosome and polymorphism of the coagulation factor IX gene (hemophilia B locus). Proc Natl Acad Sci U S A. 1984; 81(2):498-502. PMC: 344705. DOI: 10.1073/pnas.81.2.498. View

Winship P, Anson D, Rizza C, Brownlee G . Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms. Nucleic Acids Res. 1984; 12(23):8861-72. PMC: 320424. DOI: 10.1093/nar/12.23.8861. View

Sarkar G, Sommer S . RNA amplification with transcript sequencing (RAWTS). Nucleic Acids Res. 1988; 16(11):5197. PMC: 336733. DOI: 10.1093/nar/16.11.5197. View

Yoshitake S, Schach B, Foster D, Davie E, Kurachi K . Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry. 1985; 24(14):3736-50. DOI: 10.1021/bi00335a049. View

10.

Saiki R, Gelfand D, Stoffel S, Scharf S, Higuchi R, Horn G . Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988; 239(4839):487-91. DOI: 10.1126/science.2448875. View

11.

Youssoufian H, Antonarakis S, Bell W, Griffin A, Kazazian Jr H . Nonsense and missense mutations in hemophilia A: estimate of the relative mutation rate at CG dinucleotides. Am J Hum Genet. 1988; 42(5):718-25. PMC: 1715175. View

12.

Vidaud M, Chabret C, Gazengel C, Grunebaum L, Cazenave J, Goossens M . A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B. Blood. 1986; 68(4):961-3. View

13.

Koeberl D, Bottema C, Buerstedde J, Sommer S . Functionally important regions of the factor IX gene have a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG. Am J Hum Genet. 1989; 45(3):448-57. PMC: 1683422. View

14.

Antonarakis S, Kazazian Jr H . The molecular basis of hemophilia A in man. Trends Genet. 1988; 4(8):233-7. DOI: 10.1016/0168-9525(88)90156-4. View

15.

Ingram G . The history of haemophilia. J Clin Pathol. 1976; 29(6):469-79. PMC: 476103. DOI: 10.1136/jcp.29.6.469. View

16.

Barrai I, Cann H, Cavalli-Sforza L, Barbujani G, De Nicola P . Segregation analysis of hemophilia A and B. Am J Hum Genet. 1985; 37(4):680-99. PMC: 1684610. View

17.

Saiki R, Bugawan T, Horn G, Mullis K, Erlich H . Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature. 1986; 324(6093):163-6. DOI: 10.1038/324163a0. View

18.

Chen S, Scott C, Schoof J, Lovrien E, Kurachi K . Factor IXPortland: a nonsense mutation (CGA to TGA) resulting in hemophilia B. Am J Hum Genet. 1989; 44(4):567-9. PMC: 1715568. View

19.

Stoflet E, Koeberl D, Sarkar G, Sommer S . Genomic amplification with transcript sequencing. Science. 1988; 239(4839):491-4. DOI: 10.1126/science.3340835. View

20.

Cooper D, Youssoufian H . The CpG dinucleotide and human genetic disease. Hum Genet. 1988; 78(2):151-5. DOI: 10.1007/BF00278187. View